DGX vs RNLXY: stock comparison and AI forecast
Quest Diagnostics Inc (DGX) and Renalytix Plc (RNLXY) compared on price performance, valuation, profitability and the daily AI forecast. · Alpha · vs market
Share
DGX Quest Diagnostics Inc
- Market Cap
- $27.18B
- P/E Ratio
- 24.6x
- Size
- large-cap
- AI Forecast
RNLXY Renalytix Plc
- Market Cap
- n/a
- P/E Ratio
- –
- AI Forecast
- NO CURRENT FORECAST
Which one does the AI model favor?
Intratio's model scores both stocks every trading day. Sign in to see their current direction; the exact ratings and forecasts come with a plan or a free follow slot.
Key facts
- DGX turns 8064.3% of its revenue into net income, against -1179.8% for RNLXY.
- DGX yields 1.36% in dividends; RNLXY pays none.
- Both companies share the SEC industry classification Services-Medical Laboratories.
Fundamentals side by side
Trailing twelve months.
Valuation & Market
| Metric | DGX | RNLXY |
|---|---|---|
| Market Cap | $27.18B | – |
| P/E Ratio | 24.61x | – |
| P/B Ratio | 3.56x | – |
| Dividend Yield | 1.36% | – |
| EPS | $10.04 | $-0.12 |
| Book Value/Share | $69.37 | – |
| Revenue/Share | $0.13 | – |
| FCF/Share | $12.50 | – |
Profitability & Margins
| Metric | DGX | RNLXY |
|---|---|---|
| ROE | 14.8% | – |
| ROA | 6.6% | -520.3% |
| ROIC | 11.2% | – |
| Gross Margin | -56457.1% | 10.4% |
| Operating Margin | 12307.1% | -1332.8% |
| Net Margin | 8064.3% | -1179.8% |
| EBT Margin | 10871.4% | -1471.3% |
| Tax Rate | 22.5% | -0.0% |
Financial Health
| Metric | DGX | RNLXY |
|---|---|---|
| Current Ratio | 1.70x | – |
| Quick Ratio | 1.58x | – |
| D/E Ratio | 1.21x | – |
| Financial Leverage | 2.26x | – |
| Interest Coverage | – | -26.3x |
| Working Capital | $1.28B | – |
Cash Flow
| Metric | DGX | RNLXY |
|---|---|---|
| Operating Cash Flow | $1.95B | -$26M |
| Free Cash Flow | $1.38B | – |
| Capital Spending | -$576M | – |
| OCF Growth YoY | 3.5% | – |
| FCF Growth YoY | -1.3% | – |
| FCF/Sales | 9821.4% | – |
| CapEx/Sales | 4114.3% | – |
Operational Efficiency
| Metric | DGX | RNLXY |
|---|---|---|
| Asset Turnover | 0.00x | – |
| Receivables Turnover | 0.0x | – |
| Inventory Turnover | 36.3x | – |
| Fixed Assets Turnover | 0.0x | – |
| Days Sales Outstanding | 44634 days | – |
| Days Inventory | 10 days | – |
| Payables Period | 76 days | – |
| Cash Conversion Cycle | 44569 days | – |
Income Statement
| Metric | DGX | RNLXY |
|---|---|---|
| Total Revenue | $14M | – |
| Operating Income | $1.72B | -$28M |
| Net Income | $1.13B | -$25M |
| R&D Expense | – | $9M |
| SG&A Expense | $2.06B | – |
| Cost of Goods Sold | $7.92B | $2M |
Dividend & Shareholder Information
| Metric | DGX | RNLXY |
|---|---|---|
| Dividends Per Share | $3.35 | – |
| Payout Ratio | 33.4% | – |
| Shares Outstanding | 110M | – |
| Net Income Growth | 16.5% | – |
| EPS Growth | 17.8% | – |
DGX vs RNLXY: stock comparison and AI forecast
Which one does Intratio's AI model rank higher, DGX or RNLXY?
Intratio's model scores both stocks every trading day. Sign in to see their current direction; the exact ratings and forecasts come with a plan or a free follow slot.
More comparisons
This analysis is generated automatically using our proprietary AI systems and should not be considered personalized investment advice. Past performance does not guarantee future results. Always conduct your own research and consider consulting a financial advisor before making investment decisions.